The decision will “help EU risk managers determine when products should be withdrawn from the market as a precautionary public health measure”, EFSA said.
From nausea and exhaustion to emotional shifts and social awkwardness, people on GLP-1 medications are sharing the side effects they didn't expect — and rarely see talked about.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results